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Edited by Michael R. BubbAbstract Filamin plays an important role in actin cytoskeleton
organization, membrane stabilization, and anchoring of trans-
membrane proteins. Using short interfering RNA (siRNA) to
selectively target the ﬁlamin A gene and silence its expression,
we studied the role of ﬁlamin A in G protein coupled receptor
(GPCR) signaling. Silencing of ﬁlamin A protein expression
was determined by immunoblotting and immunoﬂuorescence.
Functional consequences of ﬁlamin A gene silencing were mea-
sured by studying its role in MAPK signaling pathways activated
by the Ca2+-sensing receptor. This work deﬁnes ﬁlamin A
involvement in GPCR signaling pathways and describes an addi-
tional method for studying its function.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The actin cytoskeleton plays a central role in many cell func-
tions such as the maintenance of asymmetric (polarized) cell
shape, the control of cell division, adhesion and migration,
and the regulation of membrane protein sorting and signal
transduction [1–3]. Dynamic changes in the actin cytoskeleton
(assembly and disassembly) are regulated in part by small G
proteins, particularly Rho-dependent signaling pathways
[4,5]. All of these events are guided by the action of a large
number of actin cross-linking, severing, and sequestering pro-
teins. Filamin, also known as actin-binding protein or ABP-
280, was the ﬁrst protein identiﬁed which produces isotropic
cross-linked three-dimensional orthogonal networks with actin
ﬁlaments in the cortex and at the leading edge of cells. In hu-
mans three ﬁlamin genes that code ﬁlamin proteins (ﬁlamin A,
B, and C, also called a ﬁlamin, b ﬁlamin and c ﬁlamin) have
been identiﬁed, and alternative splicing may allow for multipleAbbreviations: GPCR, G protein coupled receptor; HEK, human
embryo kidney; CaR, Ca2+-sensing receptor; SAPK/JNK, stress-acti-
vated protein kinases/c-Jun N-terminal kinase; ERK, extracellular
signal-regulated kinase; SEK1, SAPK/ERK kinase 1; MAPK, mito-
gen-activated protein kinase
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ber of this family and is of fundamental biologic importance
[7], while ﬁlamin B is expressed within the central nervous sys-
tem and ﬁlamin C shows more restricted expression in skeletal
and cardiac muscles [8]. Homozygous knock-out mice die in
utero, and ﬁlamin-null cells are non-motile and sensitive to
mechanical injury [9,10]. Recent studies show that mutations
of the ﬁlamin A gene lead to a broad range of congenital mal-
formations, aﬀecting craniofacial structures, the skeleton,
brain, viscera and urogenital tract [10]. At the cellular level, ﬁl-
amin A eﬃciently organizes actin ﬁlaments into a three dimen-
sional gel by cross-linking actin ﬁlaments, and links the actin
cytoskeleton to the plasma membrane via its association with
a variety of membrane proteins [7].
Filamin A can also act as a scaﬀolding protein for cell signal-
ing systems because it binds over 20 diverse cellular proteins,
including membrane receptors and intracellular signaling mol-
ecules [5–7]. For example, ﬁlamin A interacts directly and
selectively with G protein coupled receptors (GPCR) such as
dopamine D2 and D3 receptors [11,12], the calcitonin receptor,
[13], and the Ca2+-sensing receptor (CaR) [14–16], and it is in-
volved in the regulation of their signaling pathways. Several
small G proteins (Rho, Rac, CDC42, RabA and Rab22) also
bind to the C-terminus of ﬁlamin A, in some cases requiring
the GTP-form for binding [7]. Filamin A also serves as a scaf-
folding protein for mitogen-activated protein kinase kinase-4
(MKK-4 or SEK-1), a kinase that activates stress-activated
protein kinase (SAPK) to phosphorylate c-Jun [17] in pro-
grammed cell death. These data indicate that ﬁlamin plays
a role in the function of some GPCR-mediated signaling
complexes.
Using the yeast two-hybrid assay system and experiments
performed in ﬁlamin A deﬁcient (M2) and replete (A7) mela-
noma cells, ﬁlamin A has been demonstrated to interact specif-
ically with GPCRs, small G proteins and eﬀectors, and to
regulate their cellular signaling systems [12–17]. However, ﬁl-
amin A deﬁcient cells have a number of abnormalities includ-
ing altered structure of the Golgi network, abnormal
cytoplasmic traﬃcking and protein sorting which can lead to
abnormal localization of signaling components and other pro-
teins [7,18] that could cause disordered or interrupted cell sig-
naling. Recently, a revolutionary method has been used to
study loss-of-function gene phenotypes in vivo. Short interfer-
ing RNA (siRNA) mediates the recognition and degradation
of its homologous mRNA, leading to silencing of the target
gene expression [19,20]. To gain more information about theblished by Elsevier B.V. All rights reserved.
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NAs that are speciﬁc for the ﬁlamin A gene into human em-
bryo kidney (HEK) 293 cells that stably express the CaR,
and analyzed the expression of ﬁlamin A and its eﬀect on
CaR-mediated signaling. We found that two of these siRNAs
signiﬁcantly blocked ﬁlamin A gene expression and that this
silencing of ﬁlamin A expression attenuated CaR-activated
mitogen-activated protein kinase (MAPK) signaling pathways.2. Materials and methods
2.1. Materials
All chemicals were purchased from Sigma Chemicals or Fisher Sci-
entiﬁc unless speciﬁed otherwise. The monoclonal anti-CaR antibody
and CaR-expressing HEK 293 cells were described earlier [21]. G418
sulfate and cell culture reagents were purchased from Life Technolo-
gies. The SuperSignal West Pico chemiluminescent substrate and
BCA protein assay reagent were obtained from Pierce. The monoclo-
nal anti-ﬁlamin antibody was purchased from Serotec (Raleigh, NC).
The polyclonal anti-FAK, anti-JNK1 and monoclonal anti-a-actin
(C-2) antibodies were purchased from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA). The polyclonal anti-phospho-ERK, anti-total
ERK and anti-phospho-SAPK/JNK (Thr-183/Tyr-185) antibodies
were supplied by Cell Signaling Technology (Beverly, MA). The Alexa
Fluor 488 goat anti-mouse IgG (green) and Texas Red X-phalloidin
were obtained from Molecular Probes (Eugene, OR).
2.2. siRNA and transfection
The synthetic siRNA oligoribonucleotides with symmetric 3 0 TT
overhangs were purchased from Dharmacon RNA Technologies
(Lafayette, CO). The CaR-expressing HEK 293 cells were transiently
transfected with synthetic siRNA using Lipofectamine 2000 reagent
from Invitrogen (Carlsbad, CA), and incubated at 37 C for the peri-
ods of time shown in ﬁgure legends. The medium was removed and
washed once with 1· PBS, and the cultures were lysed with 1· loading
buﬀer without bromophenol blue. The cell lysates were centrifuged at
15000 rpm for 1 h at 4 C. The protein concentrations in the cell ly-
sates were determined using the BCA protein assay reagent with
BSA as a standard.
2.3. Immunoblotting and immunocytochemistry
Samples with equal amounts of cellular protein were subjected to 6%
or 11% SDS–PAGE, processed for immunoblotting with the antibod-
ies indicated, and visualized with enhanced chemiluminescence. For
quantitative measurement of speciﬁc proteins, the speciﬁc band of
the protein on the immunoblot ﬁlms from three individual experiments
was scanned and the optical density was measured using Scion Image
software. The data were analyzed for signiﬁcance using one-way re-
peated measures of ANOVA followed by Tukey’s test for comparisons
with or without siRNA.
CaR-expressing HEK 293 cells were grown in 12-well plates with
glass coverslips for two days. At 40–60% conﬂuence, the cells were
transfected with synthetic siRNA oligonucleotides (100 nM) using
Lipofectamine 2000. Three days after transfection, the coverslips
were ﬁxed with cold 4% paraformaldehyde for 20 min, permeabilized
with 0.05% saponin, and processed for immunoﬂuorescence using a
monoclonal anti-ﬁlamin antibody as a primary antibody with Texas
Red X-phalloidin, and Alexa Fluor 488 goat anti-mouse IgG as a sec-
ondary antibody. The coverslips were observed by ﬂuorescent micros-
copy (Zeiss, Model LSM-5 Pascal) and images were collected using the
Axiovert 200 program (Zeiss).3. Results
3.1. Silencing of ﬁlamin A gene expression by siRNA
Four ﬁlamin-speciﬁc siRNA sequences were chosen using
the Dharmacon siDESIGN Center. The sequences were tested
for speciﬁcity using the NCBI BLAST analysis. These se-quences (bold) appear to be conserved in ﬁlamin A because
they are the same or diﬀer by only one nucleotide (underlined)
between the human and mouse ﬁlamin A genes (Table 1). The
siRNA duplexes were chemically synthesized and delivered
into the CaR-expressing HEK 293 cells using Lipofectamine
2000 reagent. To determine the eﬀect of the siRNAs on ﬁlamin
A gene expression and the kinetics of silencing of ﬁlamin A
gene expression at the protein level, separate wells of cells
transfected with each of the four siRNAs, the cells were grown
for diﬀerent periods of time, and then analyzed for ﬁlamin A
protein expression by immunoblotting using an antibody
against ﬁlamin A. As shown in Fig. 1A, transfection of the
cells with siRNA-5 and siRNA-7 resulted in a signiﬁcant de-
crease in the level of ﬁlamin A protein, whereas siRNA-1
and siRNA-3 had a minimal eﬀect. By three days after trans-
fection, ﬁlamin A gene expression was substantially reduced
(40–50%) compared to non-transfected cells, and this reduc-
tion was even greater at ﬁve days after transfection (70–
90%). To demonstrate the speciﬁcity of the siRNAs on the
target gene, the samples were also processed for immunoblot-
ting using antibodies against FAK, actin and the CaR. As ex-
pected, none of the four siRNAs signiﬁcantly altered the levels
of FAK, actin or CaR protein. Fig. 2 shows a dose-dependent
reduction in ﬁlamin A gene expression by transfection of siR-
NA-5 or siRNA-7 into CaR-expressing HEK 293 cells.
Next, we performed immunocytochemistry to evaluate the
pattern of inhibition of ﬁlamin A protein expression in
HEK-293 cells. The four diﬀerent siRNAs were transfected
into CaR-expressing HEK 293 cells, the cells were grown for
three days, and then processed for immunoﬂuorescence using
an antibody against ﬁlamin A. The cells that were transfected
with siRNA-5 and siRNA-7 showed a marked reduction in the
number of ﬁlamin A staining cells (Fig. 3C and D), while the
cells transfected with siRNA-1 and siRNA-3 appeared not to
be aﬀected (Fig. 3A and B). Texas Red X-phalloidin staining
actin was used as a marker for identifying the cells.3.2. Eﬀect of ﬁlamin A gene silencing on CaR-mediated signaling
Previous studies demonstrate that ﬁlamin A interacts di-
rectly with the SAPK activator (MKK4 or SEK1) in the regu-
lation of the SAPK/JNK signaling pathway [17]. Recently, we
demonstrated that the CaR induces programmed cell death via
SEK1-SAPK/JNK-dependent activation and c-Jun phosphor-
ylation [22]. To test the eﬀect of silencing of the ﬂamin A gene
on CaR-mediated signaling, HEK 293 cells that stably express
the CaR were transfected with 100 nM siRNA–7, and grown
for ﬁve days. The cells were incubated in medium containing
either 5 mM CaCl2 to activate CaR-mediated signaling path-
ways or 1 mM CaCl2, a concentration at which the CaR is
not active in our system [21], for 24 h. The samples were pro-
cessed for immunoblotting using antibodies against ﬁlamin A,
JNK1, CaR and phospho-SAPK/JNK. As expected, transfec-
tion of CaR-expressing cells with siRNA-7 resulted in approx-
imately an 80% reduction in ﬁlamin A gene expression.
Silencing of ﬁlamin A expression also caused a signiﬁcant de-
crease in CaR-induced phosphorylation of SAPK/JNK
(Fig. 4). The level of expression of two key components in this
signaling cascade, the CaR and JNK1, were not aﬀected by the
siRNAs.
Using ﬁlamin A deﬁcient (M2) and replete (A7) melanoma
cells that were transiently transfected with the CaR, we found
Fig. 1. Time course of silencing of ﬁlamin A gene expression by siRNAs. (A) CaR-expressing HEK 293 cells were transfected with siRNAs (100 nM)
for the periods of time shown. At each time point, the cells were harvested and the samples were processed for immunoblotting using antibodies
against ﬁlamin A, FAK, actin and CaR. (B) The ﬁlamin A speciﬁc band on the immunoblot ﬁlms taken from three individual experiments performed
with duplicate samples were scanned and the optical density was measured. The values with siRNAs were statistically diﬀerent from those without
siRNA. *P < 0.05; **P < 0.01.
Table 1
siRNAs used in cell transfection
siRNA Sequence Target gene
01 AAAAUGCACCGCAAGCACAAC Human ﬁlamin A (437)
AAAAUGCACCGCAAGCACAAC Mouse ﬁlamin A (370)
03 AACAGCCGACUUCAAGGUGUA Mouse ﬁlamin A (1605)
AACAGCTGACUUCAAGGUGUA Human ﬁlamin A (1671)
05 AAAAGUGGCAUCCAAGAUUGU Human ﬁlamin A (3180)
AAAAGUAGCAUCCAAGAUUGU Mouse ﬁlamin A (3114)
07 AAAGGUGCUGCCUACUCAUGA Human ﬁlamin A (4785)
AAAGGUGCUGCCUACACAUGA Mouse ﬁlamin A (4584)
Fig. 2. Concentration dependence of siRNA-mediated silencing of
ﬁlamin A gene expression. CaR-expressing HEK 293 cells were
transfected with siRNAs at concentrations of 50 nM (1), 100 nM (2)
150 nM (3) and 200 nM (4) or without siRNA (0) and grown for 3
days. The cells were harvested and processed for immunoblotting using
antibodies against CaR, ﬁlamin A and actin.
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nal-regulated kinase (ERK) signaling [14]. A similar conclu-
sion was obtained from experiments in which expression of a
peptide corresponding to the region of ﬁlamin that interacts
with the CaR inhibited CaR-stimulated ERK activity [15].
Here, using siRNA to silence ﬁlamin A gene expression, we
measured the eﬀect of siRNA on CaR-stimulated ERK activa-
tion. Treatment of cells with siRNA-7 caused an approxi-
mately 65% reduction in ﬁlamin A expression, and lead to
an 85% decrease in CaR-stimulated ERK activation while
the CaR and total ERK are unchanged (Fig. 5). These resultsdemonstrate that ﬁlamin A is associated with the CaR-regu-
lated MAPK signaling system.4. Discussion
The use of siRNA to silence gene expression and study gene
function and protein interactions has broad and increasing
applications in mammalian cells. In the present study, we em-
ployed four speciﬁc siRNAs to silence ﬁlamin A gene expres-
sion, two of which had a minimal eﬀect and served as
negative controls, and two of which resulted in a 50–90%
reduction in ﬁlamin A protein expression. Gene silencing was
measured at the protein level by immunoblotting and immuno-
ﬂuorescence, and functional consequences of ﬁlamin A gene
silencing were measured by studying its role in GPCR-medi-
ated signaling systems. The central observation of this report
is that siRNAs can selectively silence ﬁlamin A gene expression
in CaR-expressing HEK 293 cells, and that this silencing of ﬁl-
amin A gene expression further leads to attenuation of CaR-
mediated MAPK signaling (ERK and JNK).
It is well established that ﬁlamin organizes the actin cytoskel-
eton, anchors transmembrane proteins to stabilize the mem-
brane, and acts as a scaﬀold for signaling molecules to
regulate cell signaling systems. Recently it has become clear
that ﬁlamin also has functions related to protein traﬃcking that
aﬀect the selective insertion of membrane receptors, transport-
ers, channels, enzymes, cell adhesion molecules and junctional
components into distinct plasma membrane domains, and that
it acts as a scaﬀold for signaling proteins [1–3,22–24]. Using the
Fig. 3. Immunoﬂuorescence of HEK 293 cells transfected with siRNAs. HEK 293 cells that stably express the CaR were cultured on glass coverslips
and transfected with 100 nM ﬁlamin A siRNA-1 (A), siRNA-3 (B), siRNA-5 (C) or siRNA-7 (D), and grown for 3 days. The cells were processed for
immunoﬂuorescence for ﬁlamin A and F-actin.
Fig. 4. Eﬀect of ﬁlamin A speciﬁc siRNAs on c-Jun phosphorylation. CaR-expressing HEK 293 cells were transfected with 100 nM siRNA-7, grown
for ﬁve days, and for the last 24 h in the presence of 1 or 5 mM CaCl2. The cells were harvested and processed for immunoblotting using antibodies
against ﬁlamin A, JNK1, CaR and phospho-SAPK/JNK (P-JNK). The speciﬁc bands representing these proteins on the immunoblot ﬁlms taken
from three individual experiments performed with duplicate samples were scanned and the optical density was measured. The values with siRNAs
were statistically diﬀerent from those without siRNA. **P < 0.01.
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ways in ﬁlamin A deﬁcient (M2) and replete (A7) melanoma
cells, a number of investigators have demonstrated that ﬁlamin
A can selectively interact with G protein coupled receptors
(dopamine receptors and the CaR), small GTP-binding pro-
teins (Rho, Rac and CDC42) and their eﬀectors (SEK1), and
that ﬁlamin is involved in the function of these cell signaling
systems [7].
Given the many functions of ﬁlamin A, a ﬁlamin-null cell
line could have signiﬁcant abnormalities in a number of areasin addition to cell signaling that would confound analysis of
the speciﬁc role of ﬁlamin in cell signaling [9,10]. Filamin A-
null cells could have alterations in the structure and function
of the Golgi network that would aﬀect cytoplasmic vesicle traf-
ﬁcking, protein sorting, and localization. Abnormalities of
these processes could result in abnormal signaling and could
be confused with a speciﬁc requirement for ﬁlamin in a signal-
ing pathway as a scaﬀold or organizer of signaling proteins
[9,10]. Consequently, in ﬁlamin A-null cells it may be diﬃcult
to demonstrate that the ﬁlamin A protein itself is a required
Fig. 5. Eﬀect of ﬁlamin A speciﬁc siRNAs on ERK activation. CaR-expressing HEK 293 cells were transfected with 100 nM siRNA-7, grown for ﬁve
days, and then treated with 1 or 5 mM CaCl2 for 5 min. The cells were harvested and processed for immunoblotting using antibodies against ﬁlamin
A, total ERK (T-ERK), CaR and phospho-ERK (P-ERK). The speciﬁc bands representing these proteins on the immunoblot ﬁlms taken from three
individual experiments performed with duplicate samples were scanned and the optical density was measured. The values with siRNAs were
statistically diﬀerent from those without siRNA. *P < 0.05; **P < 0.01.
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permissive for correct cell assembly that is also required for
signaling. With the use of transient expression of siRNAs,
the cell has presumably assembled correctly and an ﬁlamin
expression is then reduced, so proteins that do not require
interaction with ﬁlamin for correct processing or localization
are presumably in place, and the cells are less abnormal than
cells that if they had never expressed ﬁlamin. Additionally,
the expression of ﬁlamin may not be eliminated completely
even in cells that take up the siRNAs resulting in some pre-
served ﬁlamin function, and presumably less abnormal struc-
ture. Flanagan etal [18] reported that M2 cells express low
levels of ﬁlamin B. Although we do not know if a small
amount of ﬁlamin B is expressed in HEK 293 cells, the signal-
ing function we analyze here is associated with ﬁlamin A.
In HEK 293 cells that express the CaR stably, we did not
ﬁnd a signiﬁcant change in total CaR expression with the
introduction of siRNA and reduced ﬁlamin expression. The
lack of change in CaR expression in our current studies in con-
trast to those of others [25] could be a result of both the stable
expression of the CaR and siRNA reducing, not eliminating
ﬁlamin expression over a relatively short period of time. This
temporary silencing of ﬁlamin did not appear to aﬀect cell
morphology, although the cells were relatively conﬂuent
(Fig. 3). The use of transiently transfected siRNA into CaR-
expressing HEK 293 cells to target the ﬁlamin A gene and to
silence its expression may avoid potential problems arising in
ﬁlamin-null cells. Our data demonstrate that ﬁlamin A itself
is directly involved in CaR-mediated signaling systems, and
provide an approach in addition to analysis of the ﬁlamin-null
cells to deﬁne of its functions.
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